Charlotte Ngo
Charlotte Ngo is an expert in Oncology at INSERM (France). Charlotte Ngo has authored 114 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 372 (community average: 125). How the SLR is computed.
Oncology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2007 - 2026
Number : 114
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Inventory and needs assessment in francophone LMICs for education, screening and optimal management of breast cancer. The ELISA study. PMID 41791919 — breast neoplasms, needs assessment, neoplasms, enzyme-linked immunosorbent assay, breast, therapeutics, education | Bull Cancer | 2026 | 0 |
| Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study. PMID 41674582 — gastrointestinal stromal tumors, neoplasms, pathology, exons, deep learning, protein-tyrosine kinases, tyrosine, therapeutics, learning, mutation, landslides | medRxiv | 2026 | 0 |
| [Impact of precariousness on breast cancer care in the Île-de-France region: Results of the DESSEIN study]. PMID 38876896 — diagnosis, breast neoplasms, health literacy | Bull Cancer | 2024 | 0 |
| [Time and space in the care pathways of women suffering from breast cancer]. PMID 38879410 — breast neoplasms, neoplasms, breast, therapeutics | Bull Cancer | 2024 | 0 |
| Simultaneous quantification of four hormone therapy drugs by LC-MS/MS: Clinical applications in breast cancer patients. PMID 38367520 — anastrozole, fulvestrant, estrogens, breast neoplasms, pharmaceutical preparations, chemistry, pharmaceutical, neoplasms, drug monitoring, letrozole, hormones, breast, therapeutics | J Pharm Biomed Anal | 2024 | 4 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Cancer and Literacy in Health NCT05008497 — neoplasms, psychometrics, health literacy, literacy | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map